((自动化翻译由路透提供，请见免责声明 ))
1月14日 - ** 制药商礼来 股价下跌3.5%，至769美元
** 礼来预计 (link) 减肥药 Zepbound 第四季度销售额为 19 亿美元，低于预期的 20.8 亿美元 - LSEG 数据
** 预计糖尿病药物Mounjaro第四季度销售额为35亿美元，低于预期的53.5亿美元
** 公司预计2025年营收将在580亿至610亿美元之间，高于分析师预计的585.2亿美元
** 称 2024 年第四季度营收预计约为 135 亿美元，比之前预期的低端低 4 亿美元。
** 分析师预计第四季度收入为 139.4 亿美元
** 2024 年 LLY 股价上涨约 32
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.